Chris Fox Email & Phone Number

Appointed Executive Vice President, U.S. Commercial at Teva Pharmaceuticals in November 2023, Chris leads all commercial activities in the U.S., including P&L accountability for our generics, biosimilars and innovative medicines business and Teva US sites. She also serves on Teva’s Executive Committee.Chris has more than 30 years of healthcare industry experience with leadership roles in sales, marketing, and commercial operations, responsible for teams ranging from 2500+ associates to small, nimble consulting teams. With a deep understanding of issues affecting the pharmaceutical and biotech sectors, as well as expertise across a range of therapy areas. She is passionate about creating others-focused, inclusive, team-oriented, and performance driven cultures that apply the talents of diverse individuals and teams to transform the way a company does business. Prior to Teva, Chris served as President at Novartis Gene Therapies since December 2021. Previously, she was vice president and general manager for the Bone, Cardiometabolic and Nephrology business for Amgen and also served as the general manager of Amgen’s United Kingdom and Ireland affiliate. Earlier in her career, she held leadership positions at Merck, Takeda, and several startups.Chris’s passion and experience lie in:• Leading organizations to effectively build commercial organizations to support changing business environments and industry needs• Long-term strategic planning based and establishing a clear, long-term vision and leading the development and execution of actionable strategic plans for complex organizations.• Delivering results evidenced by setting ambitious objectives and leading teams to over-deliver on execution and revenue goals. • Putting people and patients at the center of everything.

Listed skills include Sales Management, Hospitals, Sales Force Effectiveness, Pharmaceutical Sales, and 26 others.

• 

  University Of Wisconsin-Whitewater

  Marketing